Kawasaki Disease Treatment and Care

Effective treatment and comprehensive care for Kawasaki Disease at Liv Hospital.

At Liv Hospital, children with Kawasaki Disease receive expert care, including IVIG and aspirin therapy, to ensure heart protection and full recovery.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Kawasaki Disease Treatment and Care

What Is the Goal of Kawasaki Disease Treatment at Liv Hospital?

The primary objective in treating Kawasaki Disease is to “quench” the systemic inflammation as quickly as possible to prevent the development of coronary artery aneurysms. Because the risk of heart damage is highest during the first 10 days of the fever, treatment is considered a medical emergency. When administered correctly and early, the standard treatment protocols reduce the risk of coronary complications from roughly 25% to less than 5%.

At Liv Hospital, we follow the “Gold Standard” international protocols established by the American Heart Association and the Pediatric Infectious Diseases Society. Our approach involves inpatient hospitalization for close monitoring of the heart, kidneys, and immune system.

Intravenous Immunoglobulin (IVIG)

IVIG is the cornerstone of Kawasaki treatment. It is a purified blood product containing a wide range of antibodies from healthy donors.

The Mechanism: IVIG helps “reset” the child’s overactive immune system, though the exact biological process is still being researched. It is administered as a long, continuous infusion over 8 to 12 hours.
Effectiveness: In most cases, the fever disappears, and the child’s mood improves dramatically within 24 hours of receiving IVIG.

High-Dose Aspirin Therapy

While Aspirin is generally avoided in children due to Reye’s Syndrome, Kawasaki Disease is a critical exception.

Anti-Inflammatory Phase: During the high-fever stage, high doses are used to reduce vessel inflammation.
Anti-Platelet Phase: Once the fever is gone, the dose is lowered to prevent blood clots (thrombi) from forming in the inflamed coronary arteries.

Managing "IVIG-Resistant" Cases

About 10–20% of children do not respond to the first dose of IVIG (the fever returns or persists).

Second Dose: A second infusion of IVIG may be given.
Alternative Immunomodulators: If the second dose fails, we may use biological drugs like Infliximab or Etanercept, or high-dose corticosteroids to stop the vascular attack.

Continuous Cardiac Monitoring

While in the hospital, children are often placed on a heart monitor (telemetry).

Focus: We monitor for arrhythmias (irregular heartbeats) or signs of myocarditis (inflammation of the heart muscle). Rapid heart rates or changes in heart rhythm are addressed immediately by our on-call pediatric cardiologists.

Fluid and Electrolyte Management

Prolonged high fever and poor appetite can lead to severe dehydration.

IV Support: Intravenous fluids are administered to maintain blood pressure and ensure the kidneys are flushed, which is particularly important when using high-dose medications.

Anticoagulation for High-Risk Patients

If the echocardiogram reveals that an aneurysm has already formed, Aspirin alone may not be enough.

Dual Therapy: We may add medications like Warfarin or Enoxaparin (heparin) to ensure that blood does not clot inside the widened part of the artery, which could lead to a heart attack.

Fever and Comfort Care

In addition to specialized drugs, we focus on the child’s immediate comfort.

Supportive Care: Using lukewarm sponges for cooling and ensuring the child is kept in a quiet, dark environment to manage the extreme irritability common with the disease.

Liver and Kidney Protection

The medications used for Kawasaki, including high-dose Aspirin, can be taxing on the liver and kidneys.

Frequent Labs: We perform daily blood tests to monitor liver enzymes and kidney function, adjusting dosages in real-time to ensure the treatment remains safe.

Delaying Live Vaccines

Because IVIG contains antibodies from thousands of people, it can interfere with the child’s ability to respond to “live” vaccines.

Protocol: We advise parents to delay the MMR (Measles, Mumps, Rubella) and Chickenpox vaccines for 11 months after IVIG treatment to ensure the vaccines are actually effective.

Discharge Planning and "The Home Pharmacy"

Before leaving the hospital, parents are trained on the “Low-Dose Aspirin” regimen.

Safety Training: Parents are taught to stop Aspirin immediately and call the hospital if the child is exposed to the Flu or Chickenpox, as the combination of Aspirin and these specific viruses is what increases the risk of Reye’s Syndrome.

How Does Liv Hospital Manage Kawasaki Disease Treatment Effectively?

At Liv Hospital, our Pediatric Immunology and Cardiology teams collaborate to treat Kawasaki Disease. Using high-quality IVIG and precision infusion, we follow protocols for “Refractory Kawasaki” and provide 24/7 specialist coverage to protect the child’s heart.